Clinical Trial Update: Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating corticosteroid treatment for ill-defined choroidal neovascularization in age-related macular degeneration has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Corticosteroid (unspecified) (corticosteroid)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Choroidal Neovascularization, Macular Degeneration | Phase 1 | Status: COMPLETED